TGFB1 and neoplasm: Furthermore, as the effects of TGF-β inhibitors rely on inhibition of cancer invasion and metastasis, it is of critical importance to combine anti-TGF-β therapies with cytostatic drugs to counteract tumor growth [209,228] or with immune checkpoint inhibitors that can counteract the immune suppressive effects of TGF-β.